ADUS
Price
$115.98
Change
+$3.28 (+2.91%)
Updated
Nov 24, 04:59 PM (EDT)
Capitalization
2.14B
98 days until earnings call
Intraday BUY SELL Signals
SNDA
Price
$32.19
Change
-$0.41 (-1.26%)
Updated
Nov 24, 04:59 PM (EDT)
Capitalization
604.21M
128 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADUS vs SNDA

Header iconADUS vs SNDA Comparison
Open Charts ADUS vs SNDABanner chart's image
Addus HomeCare
Price$115.98
Change+$3.28 (+2.91%)
Volume$2.69K
Capitalization2.14B
Sonida Senior Living
Price$32.19
Change-$0.41 (-1.26%)
Volume$300
Capitalization604.21M
ADUS vs SNDA Comparison Chart in %
ADUS
Daily Signal:
Gain/Loss:
SNDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADUS vs. SNDA commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a Hold and SNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (ADUS: $112.70 vs. SNDA: $32.60)
Brand notoriety: ADUS and SNDA are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ADUS: 100% vs. SNDA: 76%
Market capitalization -- ADUS: $2.14B vs. SNDA: $604.21M
ADUS [@Hospital/Nursing Management] is valued at $2.14B. SNDA’s [@Hospital/Nursing Management] market capitalization is $604.21M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $114.33B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green whileSNDA’s FA Score has 1 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • SNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDA is a better buy in the long-term than ADUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 4 TA indicator(s) are bullish while SNDA’s TA Score has 5 bullish TA indicator(s).

  • ADUS’s TA Score: 4 bullish, 6 bearish.
  • SNDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SNDA is a better buy in the short-term than ADUS.

Price Growth

ADUS (@Hospital/Nursing Management) experienced а +3.33% price change this week, while SNDA (@Hospital/Nursing Management) price change was +1.05% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.41%. For the same industry, the average monthly price growth was -7.10%, and the average quarterly price growth was +2.58%.

Reported Earning Dates

ADUS is expected to report earnings on Mar 02, 2026.

SNDA is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+1.41% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADUS($2.14B) has a higher market cap than SNDA($604M). SNDA YTD gains are higher at: 41.248 vs. ADUS (-10.092). ADUS has higher annual earnings (EBITDA): 135M vs. SNDA (54.3M). ADUS has more cash in the bank: 91.2M vs. SNDA (14.1M). ADUS has less debt than SNDA: ADUS (222M) vs SNDA (678M). ADUS has higher revenues than SNDA: ADUS (1.27B) vs SNDA (352M).
ADUSSNDAADUS / SNDA
Capitalization2.14B604M355%
EBITDA135M54.3M249%
Gain YTD-10.09241.248-24%
P/E Ratio24.87N/A-
Revenue1.27B352M362%
Total Cash91.2M14.1M647%
Total Debt222M678M33%
FUNDAMENTALS RATINGS
ADUS vs SNDA: Fundamental Ratings
ADUS
SNDA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
8467
SMR RATING
1..100
72100
PRICE GROWTH RATING
1..100
6139
P/E GROWTH RATING
1..100
568
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADUS's Valuation (71) in the Medical Or Nursing Services industry is in the same range as SNDA (94) in the Hospital Or Nursing Management industry. This means that ADUS’s stock grew similarly to SNDA’s over the last 12 months.

SNDA's Profit vs Risk Rating (67) in the Hospital Or Nursing Management industry is in the same range as ADUS (84) in the Medical Or Nursing Services industry. This means that SNDA’s stock grew similarly to ADUS’s over the last 12 months.

ADUS's SMR Rating (72) in the Medical Or Nursing Services industry is in the same range as SNDA (100) in the Hospital Or Nursing Management industry. This means that ADUS’s stock grew similarly to SNDA’s over the last 12 months.

SNDA's Price Growth Rating (39) in the Hospital Or Nursing Management industry is in the same range as ADUS (61) in the Medical Or Nursing Services industry. This means that SNDA’s stock grew similarly to ADUS’s over the last 12 months.

SNDA's P/E Growth Rating (8) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ADUS (56) in the Medical Or Nursing Services industry. This means that SNDA’s stock grew somewhat faster than ADUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADUSSNDA
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
62%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
63%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ADUS
Daily Signal:
Gain/Loss:
SNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MISCX19.560.59
+3.11%
BNY Mellon Small Cap Multi-Strategy Inv
MXXIX58.990.61
+1.04%
Marsico Midcap Growth Focus Fund
WSTYX75.980.11
+0.14%
Macquarie Science and Technology Y
BKDEX11.26-0.03
-0.27%
BlackRock Defensive Advantage EM K
AEYMX14.68-0.05
-0.34%
American Century Emerging Markets Y